Examining the unanswered questions of COVID-19
In this webinar, Richard Cuthbert, PhD, reviews some of the recent advances in the COVID-19 field. He discusses questions that continue to be important in our understanding of the disease and virus, such as the continuing efficacy of existing vaccinations against new variants of concern. He also highlights research undertaken using the ZE5 Cell Analyzer, and the features that make the ZE5 Cell Analyzer well suited to infectious disease research.
Topics covered:
- Understanding gender disparity in disease severity
- The likely impact of new variants of concern
- Will current vaccinations continue to prevent severe disease?
- An immunodiagnostic assay to monitor infection and vaccination status
Richard Cuthbert, PhD,
Flow Cytometry Commercialization Manager,
Life Science Group at Bio-Rad
Richard graduated with a Bachelor of Science in Biomedical Chemistry in 2000, and obtained his PhD in regenerative medicine at the University of Leeds in 2014. He was a Post-Doctoral Researcher at the University of Leeds from 2014-2019, where his primary research interests were stem cell biology, rheumatology, and immunology. He joined Bio-Rad as a Regional Flow Cytometry Specialist in 2019.